The Effect of Late Na Current Blocker Mexiletine on Giant T-wave Electrical Alternans(STOP-TWA)
Not Applicable
Recruiting
- Conditions
- Giant T-wave Electrical Alternans
- Interventions
- Other: Conventional therapy
- First Posted Date
- 2022-11-16
- Last Posted Date
- 2024-04-04
- Target Recruit Count
- 50
- Registration Number
- NCT05619120
- Locations
- 🇨🇳
First Affiliated Hospital of Xian Jiantong University, Xi'an, Shaanxi, China
Intranasal Insulin Improves Postoperative Neurocognitive Disorders in Elderly Patients
Not Applicable
Recruiting
- Conditions
- Postoperative Neurocognitive Disorders
- Interventions
- Drug: Intranasal saline
- First Posted Date
- 2022-11-14
- Last Posted Date
- 2022-11-14
- Target Recruit Count
- 438
- Registration Number
- NCT05613491
- Locations
- 🇨🇳
First Affiliated Hospital of Xian Jiaotong University, Xi'an, Shannxi, China
Long-term Outcome of RIPC After IV Thrombolysis in AIS Patients
Completed
- Conditions
- Acute Ischemic Stroke
- Interventions
- Other: functional and medical information
- First Posted Date
- 2022-11-14
- Last Posted Date
- 2023-02-08
- Target Recruit Count
- 62
- Registration Number
- NCT05614401
- Locations
- 🇨🇳
First Affiliated Hospital of Xian Jiantong University, Xi'an, Shaanxi, China
Tislelizumab With Chemotherapy or Radiation for Neoadjuvant Therapy of Esophageal Squamous Cell Carcinoma (TINES)
Phase 4
Active, not recruiting
- Conditions
- Esophageal Squamous Cell Carcinoma
- Interventions
- First Posted Date
- 2022-11-02
- Last Posted Date
- 2023-06-29
- Target Recruit Count
- 32
- Registration Number
- NCT05603065
- Locations
- 🇨🇳
The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China
Effect of Lymphedema Prevention Program Based on Theory of Knowledge-attitude-practice on Postoperative Breast Cancer Patients
Not Applicable
Completed
- Conditions
- Breast Cancer Lymphedema
- Interventions
- Behavioral: Lymphedema prevention protocols
- First Posted Date
- 2022-10-26
- Last Posted Date
- 2022-10-26
- Target Recruit Count
- 108
- Registration Number
- NCT05595330
- Locations
- 🇨🇳
Xi 'an, XI 'an, Shaanxi, China
Nebulized Salbutamol Facilitate Management of Hyperkalemia Postreperfusion During Liver Transplantation
Not Applicable
Not yet recruiting
- Conditions
- Liver Transplantation
- Interventions
- First Posted Date
- 2022-10-21
- Last Posted Date
- 2022-10-21
- Target Recruit Count
- 100
- Registration Number
- NCT05589441
Risk Factors for Adverse Outcomes of Endovascular Revascularization in Lower Extremity Arteriosclerosis Occlusion
Recruiting
- Conditions
- Peripheral Arterial Occlusive Disease
- Interventions
- Procedure: endovascular revascularization
- First Posted Date
- 2022-10-19
- Last Posted Date
- 2024-03-06
- Target Recruit Count
- 500
- Registration Number
- NCT05586022
- Locations
- 🇨🇳
First Affiliated Hospital of Xi 'an Jiaotong University, Xian, Shaanxi, China
Efficacy and Adverse Effects of Niraparib in Ovarian Cancer.
Not yet recruiting
- Conditions
- Ovarian Cancer
- First Posted Date
- 2022-10-18
- Last Posted Date
- 2022-10-18
- Target Recruit Count
- 222
- Registration Number
- NCT05583799
Envafolimab Combined With Endostatin in Recurrent or Metastatic MSS-type Colorectal Cancer
Phase 2
- Conditions
- Colorectal Neoplasms
- Interventions
- Drug: recombinant human endostatin (endostatin)
- First Posted Date
- 2022-09-22
- Last Posted Date
- 2022-09-22
- Target Recruit Count
- 30
- Registration Number
- NCT05551247
A Study on Prevention Strategies for CKD-SHPT and Related Complications Based on General Vitamin D Supplementation
Not Applicable
Recruiting
- Conditions
- Secondary Hyperparathyroidism Due to Renal CausesVitamin D DeficiencyChronic Kidney Disease 5D
- Interventions
- Drug: High-dose vitamin D2 softgelsDrug: low-dose vitamin D2 softgelsDrug: placebo
- First Posted Date
- 2022-09-22
- Last Posted Date
- 2023-01-09
- Target Recruit Count
- 372
- Registration Number
- NCT05549154
- Locations
- 🇨🇳
The First Affiliated Hospital of Xi 'an Jiaotong University, Xi'an, Shaanxi, China
© Copyright 2025. All Rights Reserved by MedPath